会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Monitoring of heart sounds
    • 心音监听
    • US08211034B2
    • 2012-07-03
    • US11777739
    • 2007-07-13
    • Abhilash PatangayJeffrey E. StahmannRobert J. Sweeney
    • Abhilash PatangayJeffrey E. StahmannRobert J. Sweeney
    • A61B5/02
    • A61B5/025A61B5/0031A61B5/0205A61B5/029A61B5/0295A61B5/0402A61B5/053A61B5/0816A61B5/103A61B7/00A61B7/04A61N1/36521A61N1/36542A61N1/36578
    • This document discusses, among other things, a system comprising an implantable medical device (IMD) including an implantable heart sound sensor circuit configured to produce an electrical heart sound signal representative of a heart sound of a subject and a processor circuit. The processor circuit is coupled to the heart sound sensor circuit and includes a detection circuit, a heart sound feature circuit and a trending circuit. The detection circuit configured to detect a physiologic perturbation and the heart sound feature circuit is configured to identify a heart sound feature in the electrical signal. The processor circuit is configured to trigger the heart sound feature circuit in relation to a detected physiologic perturbation. The trending circuit is configured to trend the heart sound feature in relation to a recurrence of the physiologic perturbation. The processor circuit is configured to declare a change in a physiologic condition of the patient according to the trending.
    • 本文件尤其涉及一种包括可植入医疗装置(IMD)的系统,该可植入医疗装置(IMD)包括可植入的心音传感器电路,该可植入心音传感器电路被配置为产生代表对象的心脏声音的电心脏心音信号和处理器电路。 处理器电路耦合到心脏声音传感器电路,并且包括检测电路,心脏声音特征电路和趋势电路。 被配置为检测生理扰动的检测电路和心音特征电路被配置为识别电信号中的心音特征。 处理器电路被配置为相对于检测到的生理扰动触发心音特征电路。 趋势电路被配置为相对于生理扰动的复发趋向心音特征。 处理器电路被配置为根据趋势来声明患者的生理状况的变化。
    • 6. 发明申请
    • PERMISSION BASED TEXT MESSAGING
    • 基于许可的文本消息传递
    • US20120011595A1
    • 2012-01-12
    • US13242581
    • 2011-09-23
    • Robert J. Sweeney
    • Robert J. Sweeney
    • G06F21/20
    • H04W8/18H04L12/1859H04L51/38H04L63/101H04L67/26H04W4/06H04W4/12H04W4/14H04W12/06H04W12/08
    • A system and method for narrowcasting text messages to a plurality of cellular phones. The system and method allow a potential user to opt in to receive the text messages the user wants to receive. The potential user can opt in through a computer network based web page. Once the potential user sends a sign up request application to participate via the computer network, the user will receive a first text message containing an authorization code on their cell phone. The user enters the authorization code into the web page and sends the authorization code. Receipt of the authorization code back through the computer network will trigger the phone number of the potential user to be added to a list of authorized text message receivers. A narrowcaster then instructs the central computer to narrowcast text messages to the phone numbers on the list that have indicated they want to receive messages on a certain topic.
    • 一种用于将文本消息窄带化到多个蜂窝电话的系统和方法。 系统和方法允许潜在用户选择接收用户想要接收的文本消息。 潜在用户可以通过基于计算机网络的网页进行选择。 一旦潜在用户通过计算机网络发送注册请求应用程序来参与,则用户将在其手机上接收到包含授权码的第一短信。 用户将授权码输入网页并发送授权码。 通过计算机网络接收授权码将触发要添加到授权文本消息接收者列表中的潜在用户的电话号码。 然后,窄带指示器指示中央计算机将文本消息缩小到列表上已经表示希望在特定主题上接收消息的电话号码。
    • 9. 发明授权
    • Multiple pulse defibrillation for subcutaneous implantable cardiac devices
    • 多次脉搏除颤用于皮下植入式心脏装置
    • US08000786B2
    • 2011-08-16
    • US12228327
    • 2008-08-12
    • Robert J. Sweeney
    • Robert J. Sweeney
    • A61N1/00
    • A61N1/3956A61N1/3906
    • Cardiac stimulation methods and systems provide for multiple pulse defibrillation, and involve sensing a fibrillation event, determining a fibrillation cycle length associated with the fibrillation event, and delivering a plurality of defibrillation pulses to treat the fibrillation event. Defibrillation pulses are delivered using a combination of subcutaneous non-intrathoracic electrodes. Delivery of each defibrillation waveform subsequent to a first defibrillation waveform is separated in time by a delay associated with the fibrillation cycle length. Delays between defibrillation waveform delivery may be associated with a percentage of the fibrillation cycle length.
    • 心脏刺激方法和系统提供多次脉动除颤,并且涉及检测原纤化事件,确定与原纤化事件相关的原纤化循环长度,以及递送多个除颤脉冲以治疗纤维性颤动事件。 使用皮下非胸腔内电极的组合递送除颤脉冲。 在第一除颤波形之后的每个除颤波形的递送在时间上与与原纤维循环长度相关联的延迟分开。 除颤波形输送之间的延迟可能与原纤化循环长度的百分比相关。
    • 10. 发明申请
    • USE OF SIGNIFICANT POINT METHODOLOGY TO PREVENT INAPPROPRIATE THERAPY
    • 使用重要的方法来预防不明原因的治疗
    • US20110172729A1
    • 2011-07-14
    • US13004582
    • 2011-01-11
    • Robert J. SweeneyDan Li
    • Robert J. SweeneyDan Li
    • A61N1/365A61N1/39
    • A61N1/36507A61B5/0464A61N1/3925
    • An apparatus example comprises a cardiac signal sensing circuit configured to provide a sensed cardiac signal representative of cardiac depolarization events of a subject, a sampling circuit coupled to the cardiac signal sensing circuit, a therapy circuit, and a controller communicatively coupled to the sampling circuit and the therapy circuit. The controller includes a detection module configured to detect tachyarrhythmia using the cardiac signal and a signal analysis module configured to establish significant points (SPs) of the sampled cardiac signal, estimate heart rate during the tachyarrhythmia using the SPs, and provide an indication of whether noise is present in the cardiac signal using the SPs. The controller is configured to select a therapy for delivery by the therapy circuit in response to the tachyarrhythmia detection and to modify the selected therapy according to the heart rate estimation and the noise indication.
    • 装置示例包括心脏信号感测电路,其被配置为提供表示对象的心脏去极化事件的感测心脏信号,耦合到心脏信号感测电路的采样电路,治疗电路和通信地耦合到采样电路的控制器,以及 治疗电路。 所述控制器包括检测模块,所述检测模块被配置为使用所述心脏信号来检测快速性心律失常;以及信号分析模块,所述信号分析模块被配置为建立所述采集的心脏信号的有效点(SP),使用所述SP在所述快速性心律失常期间估计心率,并且提供噪声 使用SP存在于心脏信号中。 控制器被配置为选择治疗电路响应于快速性心律失常检测的递送的治疗,并且根据心率估计和噪声指示修改所选择的治疗。